Our primary interest aligns with OO7, where we aim to collaborate with vaccine manufacturers, research institutes, and biotechnology partners to further develop and optimize our adjuvant platforms and advanced delivery systems for veterinary applications. Building on our established expertise in oil-based adjuvants, emulsions, and particulate carrier technologies, we seek joint projects focused on improving the immune efficacy, safety, and durability of vaccines and other biological interventions. Our technologies can support targeted and sustained antigen delivery, enhanced immune modulation, and improved stability of biological formulations, thereby contributing to more effective preventive and therapeutic solutions. We are eager to engage in joint R&D activities to customize our carrier systems for your specific needs, aiming to demonstrate improved safety and potency in clinical trials and accelerate the delivery of effective animal health solutions to the market.

Our company is a technology-driven manufacturer specializing in veterinary vaccine adjuvants and innovative carrier systems, with extensive experience in oil-based emulsions, particulate carriers, and formulation optimization. For many years, we have supported animal health companies and research institutions by developing high-performance adjuvant platforms designed to enhance immune responses, improve antigen stability, and enable scalable manufacturing. Our multidisciplinary R&D team has strong expertise in formulation development, analytical characterization, process scale-up, and collaborative industrial research. We bridge the gap between formulation science and industrial application, offering robust solutions for antigen delivery and stability.